Skip to main content
. 2017 Jun 6;45(4):1297–1309. doi: 10.1177/0300060517710584

Table 3.

Long-term functional outcomes.

Harris hip score ITa (n = 86) PFNA-IIb (n = 88) P-value
1 month postoperatively 80.51 ± 2.91 78.18 ± 3.74 0.000*
3 months postoperatively 82.26 ± 3.02 80.91 ± 3.54 0.008*
6 months postoperatively 82.69 ± 2.93 83.66 ± 2.75 0.025*
9 months postoperatively 82.83 ± 2.79 83.70 ± 2.72 0.037*
12 months postoperatively 81.42 ± 1.78 82.06 ± 2.12 0.033*
15 months postoperatively 80.76 ± 3.43 78.49 ± 3.33 0.000*
18 months postoperatively 83.81 ± 4.38 80.39 ± 3.70 0.000*
21 months postoperatively 81.78 ± 3.85 80.30 ± 4.51 0.021*
24 months postoperatively 79.97 ± 3.60 78.01 ± 3.72 0.001*
27 months postoperatively 78.77 ± 3.41 77.49 ± 3.45 0.015*
30 months postoperatively 77.34 ± 2.97 75.00 ± 2.58 0.000*
33 months postoperatively 76.77 ± 2.89 74.65 ± 3.08 0.000*
36 months postoperatively 75.97 ± 2.30 74.14 ± 2.56 0.000*
Final follow-up 75.14 ± 3.65 71.03 ± 3.54 0.000*

Data are presented as mean ± standard deviation.

*

Statistically significant values.

IT: INTERTAN nail; PFNA-II: proximal femoral nail antirotation-Asia; aSmith & Nephew, Memphis, TN; bSynthes, Solothurn, Switzerland